Antimicrobial susceptibility testing results from 13 hospitals in Viet Nam: VINARES 2016-2017
- PMID: 33971969
- PMCID: PMC8112055
- DOI: 10.1186/s13756-021-00937-4
Antimicrobial susceptibility testing results from 13 hospitals in Viet Nam: VINARES 2016-2017
Abstract
Objective: To analyse data from 2016-17 from a hospital-based antimicrobial resistance surveillance with national coverage in a network of hospitals Viet Nam.
Methods: We analysed data from 13 hospitals, 3 less than the dataset from the 2012-13 period. Identification and antimicrobial susceptibility testing data from the clinical microbiology laboratories from samples sent in for routine diagnostics were used. Clinical and Laboratory Standards Institute 2018 guidelines were used for antimicrobial susceptibility testing interpretation. WHONET was used for data entry, management and analysis.
Results: 42,553 deduplicated isolates were included in this analysis; including 30,222 (71%) Gram-negative and 12,331 (29%) Gram-positive bacteria. 8,793 (21%) were from ICUs and 7,439 (18%) isolates were from invasive infections. Escherichia coli and Staphylococcus aureus were the most frequently detected species with 9,092 (21%) and 4,833 isolates (11%), respectively; followed by Klebsiella pneumoniae (3,858 isolates - 9.1%) and Acinetobacter baumannii (3,870 isolates - 9%). Bacteria were mainly isolated from sputum (8,798 isolates - 21%), blood (7,118 isolates - 17%) and urine (5,202 isolates - 12%). Among Gram-positives 3,302/4,515 isolates (73%) of S. aureus were MRSA; 99/290 (34%) of Enterococcus faecium were resistant to vancomycin; and 58% (663/1,136) of Streptococcus pneumoniae proportion were reduced susceptible to penicillin. Among Gram-negatives 59% (4,085/6,953) and 40% (1,186/2,958) of E. coli and K. pneumoniae produced ESBL and 29% (376/1,298) and 11% (961/8,830) were resistant to carbapenems, respectively. 79% (2855/3622) and 45% (1,514/3,376) of Acinetobacter spp. and Pseudomonas aeruginosa were carbapenem resistant, respectively. 88% (804/911) of Haemophilus influenzae were ampicillin resistant and 18/253 (7%) of Salmonella spp. and 7/46 (15%) of Shigella spp. were resistant to fluoroquinolones. The number of isolates from which data were submitted in the 2016-2017 period was twice as high as in 2012-2013. AMR proportions were higher in 2016-2017 for most pathogen-antimicrobial combinations of interest including imipenem-resistant A. baumannii, P. aeruginosa and Enterobacterales.
Conclusions: The data show alarmingly high and increasing resistant proportions among important organisms in Viet Nam. AMR proportions varied across hospital types and should be interpreted with caution because existing sampling bias and missing information on whether isolates were community or hospital acquired. Affordable and scalable ways to adopt a sample- or case-based approach across the network should be explored and clinical data should be integrated to help provide more accurate inferences of the surveillance data.
Keywords: Antimicrobial resistance; Surveillance; VINARES; Viet Nam.
Conflict of interest statement
None declared.
Figures


Similar articles
-
Antimicrobial susceptibility testing and antibiotic consumption results from 16 hospitals in Viet Nam: The VINARES project 2012-2013.J Glob Antimicrob Resist. 2019 Sep;18:269-278. doi: 10.1016/j.jgar.2019.06.002. Epub 2019 Jun 12. J Glob Antimicrob Resist. 2019. PMID: 31201995
-
Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.Ann Clin Microbiol Antimicrob. 2015 Dec 15;14:53. doi: 10.1186/s12941-015-0116-y. Ann Clin Microbiol Antimicrob. 2015. PMID: 26667651 Free PMC article.
-
Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.Ann Clin Microbiol Antimicrob. 2017 Jul 12;16(1):50. doi: 10.1186/s12941-017-0222-0. Ann Clin Microbiol Antimicrob. 2017. PMID: 28701170 Free PMC article.
-
Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.Drugs. 2022 Apr;82(5):533-557. doi: 10.1007/s40265-022-01688-1. Epub 2022 Mar 16. Drugs. 2022. PMID: 35294769 Review.
-
Multidrug-Resistant and Virulent Organisms Trauma Infections: Trauma Infectious Disease Outcomes Study Initiative.Mil Med. 2022 May 4;187(Suppl 2):42-51. doi: 10.1093/milmed/usab131. Mil Med. 2022. PMID: 35512375 Free PMC article. Review.
Cited by
-
Molecular Epidemiology of Streptococcus pneumoniae Detected in Hospitalized Pediatric Acute Respiratory Infection Cases in Central Vietnam.Pathogens. 2023 Jul 17;12(7):943. doi: 10.3390/pathogens12070943. Pathogens. 2023. PMID: 37513790 Free PMC article.
-
Resistance mechanisms and genetic relatedness among carbapenem-resistant Pseudomonas aeruginosa isolates from three major hospitals in Hanoi, Vietnam (2011-15).JAC Antimicrob Resist. 2021 Jul 27;3(3):dlab103. doi: 10.1093/jacamr/dlab103. eCollection 2021 Sep. JAC Antimicrob Resist. 2021. PMID: 34322671 Free PMC article.
-
Antimicrobial Resistance Patterns of Staphylococcus Aureus Isolated at a General Hospital in Vietnam Between 2014 and 2021.Infect Drug Resist. 2024 Jan 24;17:259-273. doi: 10.2147/IDR.S437920. eCollection 2024. Infect Drug Resist. 2024. PMID: 38283112 Free PMC article.
-
Assessing feasibility of establishing antimicrobial stewardship programmes in two provincial-level hospitals in Vietnam: an implementation research study.BMJ Open. 2021 Oct 1;11(10):e053343. doi: 10.1136/bmjopen-2021-053343. BMJ Open. 2021. PMID: 34598989 Free PMC article.
-
Trends of Colistin MIC Among Acinetobacter Baumannii and Pseudomonas aeruginosa at a First-Class Hospital in Vietnam.J Trop Med. 2025 Mar 16;2025:6165665. doi: 10.1155/jotm/6165665. eCollection 2025. J Trop Med. 2025. PMID: 40124533 Free PMC article.
References
-
- Cassini A, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66. doi: 10.1016/S1473-3099(18)30605-4. - DOI - PMC - PubMed
-
- World Health Organization . Global Action Plan on Antimicrobial Resistance. Geneva: Switzerland; 2015. - PubMed
-
- WHO, Antimicrobial resistance: global report on surveillance. Geneva, Switzerland: World Health Organization, 2014.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous